Sponsored Links
| Endo Pharmaceuticals Provides Regulatory Update On AVEED(TM) (Testosterone Undecanoate) Injection |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Endo Pharmaceuticals (Nasdaq: ENDP) announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for its extended-duration testosterone undecanoate injection, AVEED(TM), for men diagnosed with low testosterone. Low testosterone is also known as hypogonadism... Read more: Pharma Industry / Biotech Industry News From Medical News Today
|